Investment Rating - The industry investment rating is "Maintain Buy" [4] Core Viewpoints - The global exoskeleton robot market is expected to exceed $10 billion by 2025, with a compound annual growth rate (CAGR) of 33%, and the medical rehabilitation sector accounting for over 40% of this market [4][8] - Domestic market size is projected to reach 4.2 billion yuan by 2025, with a CAGR of 50% from 2023 to 2028, making it the fastest-growing single market [4][8] - International companies like Ekso Bionics, Cyberdyne, and Sarcos Robotics dominate the high-end medical market, while domestic firms such as DAI Robot and Fourier Intelligence are rapidly emerging due to cost advantages [8] Application Scenarios - **Medical Rehabilitation**: Exoskeleton robots improve rehabilitation efficiency by 60% compared to traditional methods, with a market potential of approximately 2 billion yuan in China [2][3] - **Industrial Logistics**: Deployment of exoskeletons in warehouses has led to a 300% increase in handling efficiency and an 80% reduction in injury rates [2][3] - **Military Applications**: Exoskeletons enhance soldiers' load-carrying capabilities and operational efficiency in extreme conditions [2][3] Technological Trends - **Lightweight Materials**: The use of carbon fiber has reduced the weight of exoskeletons by over 40% and improved battery life to over 16 hours [9] - **Intelligent Upgrades**: AI algorithms and brain-machine interfaces are being developed to enhance user interaction and control [9] - **Energy Technology Breakthroughs**: New solid-state batteries and self-powering systems are expected to significantly extend operational time [9] Company Developments - **Zhenjiang Co.**: Plans to produce exoskeleton robots in small batches by Q3 [10] - **Explorer Group**: Collaborating on the development of lower-limb exoskeletons, with products expected to launch by the end of the year [10] - **Precision Technology**: Testing algorithms for single-joint exoskeletons to enhance market readiness [10]